VASOMERA™, A NOVEL VPAC2-SELECTIVE VASOACTIVE INTESTINAL PEPTIDE AGONIST, ENHANCES CONTRACTILITY AND DECREASES MYOCARDIAL DEMAND IN DOGS WITH BOTH NORMAL HEARTS AND WITH PACING-INDUCED DILATED CARDIOMYOPATHY

✍ Scribed by Rio, Carlos L. del; George, Robert; Kloepfer, Pamela; Ueyama, Yukie; Youngblood, Bradley; Georgopoulos, Lynne; Arnold, Sue; Hamlin, Robert L.

• Book ID: 123393348
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 145 KB
• Volume: 61
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/S0735-1097(13)60645-2